Intens.id Versi penuh
Ekonomi Bisnis

Everest Medicines Enters Commercialization License Agreement with Mabworks for Bejescin(R) in the Asia-Pacific Market

Oleh Harian Intens 05 Jun 2026 15:30 1 menit baca

Intens.id,

 Everest Medicines (HKEX 1952.HK) announced that it has entered into a commercialization license agreement with ...
Baca juga
  1. Geger 3 Juta Penduduk Jepang Menghilang, Apa yang Terjadi?
  2. Bea Cukai Tagih Tunggakan Pabean Tiffany dan Co Plus Denda Rp97 M
  3. Indonesia, France expand research and education ties
  4. Trans Sumatra railway will not rely on state budget: Minister
Intens.id
Buka artikel versi reguler